Order Article Reprints

Jawarkar RD, Bakal RL, Mukherjee N, Ghosh A, Zaki MEA, AL-Hussain SA, Al-Mutairi AA, Samad A, Gandhi A, Masand VH. QSAR Evaluations to Unravel the Structural Features in Lysine-Specific Histone Demethylase 1A Inhibitors for Novel Anticancer Lead Development Supported by Molecular Docking, MD Simulation and MMGBSA. Molecules. 2022; 27(15):4758. https://doi.org/10.3390/molecules27154758

Jawarkar, Rahul D., Ravindra L. Bakal, Nobendu Mukherjee, Arabinda Ghosh, Magdi E. A. Zaki, Sami A. AL-Hussain, Aamal A. Al-Mutairi, Abdul Samad, Ajaykumar Gandhi, and Vijay H. Masand. 2022. "QSAR Evaluations to Unravel the Structural Features in Lysine-Specific Histone Demethylase 1A Inhibitors for Novel Anticancer Lead Development Supported by Molecular Docking, MD Simulation and MMGBSA" Molecules 27, no. 15: 4758. https://doi.org/10.3390/molecules27154758

Jawarkar, R. D., Bakal, R. L., Mukherjee, N., Ghosh, A., Zaki, M. E. A., AL-Hussain, S. A., Al-Mutairi, A. A., Samad, A., Gandhi, A., & Masand, V. H. (2022). QSAR Evaluations to Unravel the Structural Features in Lysine-Specific Histone Demethylase 1A Inhibitors for Novel Anticancer Lead Development Supported by Molecular Docking, MD Simulation and MMGBSA. Molecules, 27(15), 4758. https://doi.org/10.3390/molecules27154758